Components of vectors for gene transfer and expression in mammalian cells

Protein Expression and Purification

Volumn 17, Issue 2, 1999, Pages 183-202

  Makrides, Savvas C ^a  

^a EIC LABORATORIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; GENE TRANSFER; PROMOTER REGION; RECOMBINANT PROTEIN; VECTOR;

EUKARYOTA; MAMMALIA; UNIDENTIFIED BACULOVIRUS;

EID: 0033231184     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1137     Document Type: Review

References (248)

1. Robbins P. D., Tahara H., Ghivizzani S. C. Viral vectors for gene therapy. Trends Biotechnol. 16:1998;35-40.
2. Verma I. M., Somia N. Gene therapy - Promises, problems and prospects. Nature. 389:1997;239-242.
3. Schlesinger S. RNA viruses as vectors for the expression of heterologous proteins. Mol. Biotechnol. 3:1995;155-165.
4. García-Sastre A. Negative-strand RNA viruses: Applications to biotechnology. Trends Biotechnol. 16:1998;230-235.
5. Palese P., Zheng H. Y., Engelhardt O. G., Pleschka S., García-Sastre A. Negative-strand RNA viruses: Genetic engineering and applications. Proc. Natl. Acad. Sci. USA. 93:1996;11354-11358.
6. Roberts A., Rose J. K. Recovery of negative-strand RNA viruses from plasmid DNAs: A positive approach revitalizes a negative field. Virology. 247:1998;1-6.
7. Palese P. RNA virus vectors: Where are we and where do we need to go. Proc. Natl. Acad. Sci. USA. 95:1998;12750-12752.
8. Baron U., Gossen M., Bujard H. Tetracycline-controlled transcription in eukaryotes: Novel transactivators with graded transactivation potential. Nucleic Acids Res. 25:1997;2723-2729.
9. Blau H. M., Rossi F. M. V. Tet B or not tet B: Advances in tetracycline-inducible gene expression. Proc. Natl. Acad. Sci. USA. 96:1999;797-799.
10. Gossen M., Bonin A. L., Freundlieb S., Bujard H. Inducible gene expression systems for higher eukaryotic cells. Curr. Opin. Biotechnol. 5:1994;516-520.
11. Harvey D. M., Caskey C. T. Inducible control of gene expression: Prospects for gene therapy. Curr. Opin. Chem. Biol. 2:1998;512-518.
12. Rossi F. M. V., Blau H. M. Recent advances in inducible gene expression systems. Curr. Opin. Biotechnol. 9:1998;451-456.
13. Saez E., No D., West A., Evans R. M. Inducible gene expression in mammalian cells and transgenic mice. Curr. Opin. Biotechnol. 8:1997;608-616.
14. Marino M. H. Expression systems for heterologous protein production. BioPharm. 2:1989;18-33.
15. Goeddel D. V. Systems for heterologous gene expression. Methods Enzymol. 185:1990;3-7.
16. Datar R. V., Cartwright T., Rosen C.-G. Process economics of animal cell and bacterial fermentations: A case study analysis of tissue plasminogen activator. Bio/Technology. 11:1993;349-357.
17. Wurm F., Bernard A. Large-scale transient expression in mammalian cells for recombinant protein production. Curr. Opin. Biotechnol. 10:1999;156-159.
18. Edwards C. P., Aruffo A. Current applications of COS cell based transient expression systems. Curr. Opin. Biotechnol. 4:1993;558-563.
19. Trill J. J., Shatzman A. R., Ganguly S. Production of monoclonal antibodies in COS and CHO cells. Curr. Opin. Biotechnol. 6:1995;553-560.
20. Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 23:1981;175-182.
21. Mellon P., Parker V., Gluzman Y., Maniatis T. Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector system. Cell. 27:1981;279-288.
22. Yates J. L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 313:1985;812-815.
23. Piechaczek C., Fetzer C., Baiker A., Bode J., Lipps H. J. A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res. 27:1999;426-428.
24. Kaufman R. J. Selection and coamplification of heterologous genes in mammalian cells. Methods Enzymol. 185:1990;537-566.
25. Wahl G. M., de Saint Vincent B. R., DeRose M. L. Effect of chromosomal position on amplification of transfected genes in animal cells. Nature. 307:1984;516-520.
26. Dobie K. W., Lee M., Fantes J. A., Graham E., Clark A. J., Springbett A., Lathe R., McClenaghan M. Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus. Proc. Natl. Acad. Sci. USA. 93:1996;6659-6664.
27. Lambert J. R., Nordeen S. K. Steroid-selective initiation of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter is controlled by the site of promoter integration. J. Biol. Chem. 273:1998;32708-32714.
28. Wigler M., Sweet R., Sim G. K., Wold B., Pellicer A., Lacy E., Maniatis T., Silverstein S., Axel R. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell. 16:1979;777-785.
29. Sauer B., Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA. 85:1988;5166-5170.
30. O'Gorman S., Fox D. T., Wahl G. M. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science. 251:1991;1351-1355.
31. Karreman S., Hauser H., Karreman C. On the use of double FLP recognition targets (FRTs) in the LTR of retroviruses for the construction of high producer cell lines. Nucleic Acids Res. 24:1996;1616-1624.
32. Tanaka A. S., Tanaka H., Komuro K. A highly efficient method for the site-specific integration of transfected plasmids into the genome of mammalian cells using purified retroviral integrase. Gene. 216:1998;67-76.
33. Pei D., Yi J. A high-level mammalian expression system based on the Madin-Darby canine kidney cell line. Protein Expression Purif. 13:1998;277-281.
34. Novina C. D., Roy A. L. Core promoters and transcriptional control. Trends Genet. 12:1996;351-355.
35. Huang W. B., Wong J. M., Bateman E. TATA elements direct bi-directional transcription by RNA polymerases II and III. Nucleic Acids Res. 24:1996;1158-1163.
36. Goodrich J. A., Cutler G., Tjian R. Contacts in context: Promoter specificity and macromolecular interactions in transcription. Cell. 84:1996;825-830.
37. Blackwood E. M., Kadonaga J. T. Going the distance: A current view of enhancer action. Science. 281:1998;60-63.
38. Boam D. S. W., Davidson I., Chambon P. A TATA-less promoter containing binding sites for ubiquitous transcription factors mediates cell type-specific regulation of the gene for transcription enhancer factor-1 (TEF-1). J. Biol. Chem. 270:1995;19487-19494.
39. Kollmar R., Sukow K. A., Sponagle S. K., Farnham P. J. Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase dihydroorotase promoter. J. Biol. Chem. 269:1994;2252-2257.
40. Kaufman R. J. Vectors used for expression in mammalian cells. Methods Enzymol. 185:1990;487-511.
41. Kriegler M. Assembly of enhancers, promoters, and splice signals to control expression of transferred genes. Methods Enzymol. 185:1990;512-527.
42. Najjar S. M., Lewis R. E. Persistent expression of foreign genes in cultured hepatocytes: Expression vectors. Gene. 230:1999;41-45.
43. Wulff B. S., O'Hare M. M. T., Boel E., Theill L. E., Schwartz T. W. Partial processing of the neuropeptide Y precursor in transfected CHO cells. FEBS Lett. 261:1990;101-105.
44. Schorpp M., Jäger R., Schellander K., Schenkel J., Wagner E. F., Weiher H., Angel P. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 24:1996;1787-1788.
45. Nettelbeck D. M., Jérôme V., Müller R. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Ther. 5:1998;1656-1664.
46. Angrand P.-O., Woodroofe C. P., Buchholz F., Stewart A. F. Inducible expression based on regulated recombination: a single vector strategy for stable expression in cultured cells. Nucleic Acids Res. 26:1998;3263-3269.
47. Fishman G. I. Conditional transgenics. Trends Cardiovasc. Med. 5:1995;211-217.
48. Dhawan J., Rando T. A., Elson S. L., Bujard H., Blau H. M. Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Somat. Cell Mol. Genet. 21:1995;233-240.
49. Pavlakis G. N., Hamer D. H. Regulation of a metallothionein-growth hormone hybrid gene in bovine papilloma virus. Proc. Natl. Acad. Sci. USA. 80:1983;397-401.
50. McNeall J., Sanchez A., Gray P. P., Chesterman C. N., Sleigh M. J. Hyperinducible gene expression from a metallothionein promoter containing additional metal-responsive elements. Gene. 76:1989;81-88.
51. Makarov S. S., Jonat C., Haskill S. Hyperinducible human metallothionein promoter with a low level basal activity. Nucleic Acids Res. 22:1994;1504-1505.
52. Hu M. C. T., Davidson N. The inducible lac operator-repressor system is functional in mammalian cells. Cell. 48:1987;555-566.
53. Figge J., Wright C., Collins C. J., Roberts T. M., Livingston D. M. Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E. coli lac repressor in monkey cells. Cell. 52:1988;713-722.
54. Simons A., Tils D., von Wilcken-Bergmann B., Müller-Hill B. Possible ideal lac operator: Escherichia coli lac operator-like sequences from eukaryotic genomes lack the central GC pair. Proc. Natl. Acad. Sci. USA. 81:1984;1624-1628.
55. Riggs A. D., Suzuki H., Bourgeois S. lac repressor-operator interaction. I. Equilibrium studies. J. Mol. Biol. 48:1970;67-83.
56. Baim S. B., Labow M. A., Levine A. J., Shenk T. A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl β-D-thiogalactopyranoside. Proc. Natl. Acad. Sci. USA. 88:1991;5072-5076.
57. Ward G. A., Stover C. K., Moss B., Fuerst T. R. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc. Natl. Acad. Sci. USA. 92:1995;6773-6777.
58. Adari H., Andrews B., Ford P. J., Hannig G., Brosius J., Makrides S. C. Expression of the human T-Cell receptor Vβ5.3 in Escherichia coli by thermal induction of the trc promoter: Nucleotide sequence of the lacIts gene. DNA Cell Biol. 14:1995;945-950.
59. qts expression plasmids and evaluation of the thermosensitive lac repressor. Gene. 163:1995;35-40.
60. Andrews B., Adari H., Hannig G., Lahue E., Gosselin M., Martin S., Ahmed A., Ford P. J., Hayman E. G., Makrides S. C. A tightly regulated high level expression vector that utilizes a thermosensitive lac repressor: Production of the human T cell receptor Vβ5.3 in Escherichia coli. Gene. 182:1996;101-109.
61. Palmiter R. D., Sandgren E. P., Avarbock M. R., Allen D. D., Brinster R. L. Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. USA. 88:1991;478-482.
62. Choi T., Huang M., Gorman C., Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol. Cell. Biol. 11:1991;3070-3074.
63. Buchman A. R., Berg P. Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8:1988;4395-4405.
64. Wise R. J., Orkin S. H., Collins T. Aberrant expression of platelet-derived growth factor A-chain cDNAs due to cryptic splicing of RNA transcripts in COS-1 cells. Nucleic Acids Res. 17:1989;6591-6601.
65. Huang M. T. F., Gorman C. M. The simian virus 40 small-t intron, present in many common expression vectors, leads to aberrant splicing. Mol. Cell. Biol. 10:1990;1805-1810.
66. Khamlichi A. A., Rocca A., Cogne M. The effect of intron sequences on expression levels of Ig cDNAs. Gene. 150:1994;387-390.
67. Petitclerc D., Attal J., Théron M. C., Bearzotti M., Bolifraud P., Kann G., Stinnakre M.-G., Pointu H., Puissant C., Houdebine L.-M. The effect of various introns and transcription terminators on the efficiency of expression vectors in various cultured cell lines and in the mammary gland of transgenic mice. J. Biotechnol. 40:1995;169-178.
68. Liu Z., Cashion L. M., Pu H. Protein expression both in mammalian cell lines and in yeast Pichia pastoris using a single expression plasmid. BioTechniques. 24:1998;266-271.
69. Liu Z., Cashion L. M., Zhu L., Luo Y. A mammalian gene expression vector with blue-white selection for efficient subcloning in Escherichia coli. Anal. Biochem. 246:1997;264-267.
70. Proudfoot N. Ending the message is not so simple. Cell. 87:1996;779-781.
71. Jackson R. J., Standart N. Do the poly(A) tail and 3′ untranslated region control mRNA translation. Cell. 62:1990;15-24.
72. Gray N. K., Wickens M. Control of translation initiation in animals. Annu. Rev. Cell Dev. Biol. 14:1998;399-458.
73. Proudfoot N. Poly(A) signals. Cell. 64:1991;671-674.
74. Phillips C., Kyriakopoulou C. B., Virtanen A. Identification of a stem-loop structure important for polyadenylation at the murine IgM secretory poly(A) site. Nucleic Acids Res. 27:1999;429-438.
75. Goodwin E. C., Rottman F. M. The 3′-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation. J. Biol. Chem. 267:1992;16330-16334.
76. Pandey N. B., Chodchoy N., Liu T. J., Marzluff W. F. Introns in histone genes alter the distribution of 3′ ends. Nucleic Acids Res. 18:1990;3161-3170.
77. van den Hoff M. J. B., Labruyere W. T., Moorman A. F. M., Lamers W. H. Mammalian gene expression is improved by use of a longer SV(40) early polyadenylation cassette. Nucleic Acids Res. 21:1993;4987-4988.
78. Schmidt E. V., Christoph G., Zeller R., Leder P. The cytomegalovirus enhancer: A pan-active control element in transgenic mice. Mol. Cell. Biol. 10:1990;4406-4411.
79. Adhya S., Gottesman M. Promoter occlusion: Transcription through a promoter may inhibit its activity. Cell. 29:1982;939-944.
80. Cullen B. R., Lomedico P. T., Ju G. Transcriptional interference in avian retroviruses - Implications for the promoter insertion model of leukaemogenesis. Nature. 307:1984;241-245.
81. Proudfoot N. J. Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation. Nature. 322:1986;562-565.
82. Makrides S. C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60:1996;512-538.
83. Maa M.-C., Chinsky J. M., Ramamurthy V., Martin B. D., Kellems R. E. Identification of transcription stop sites at the 5′ and 3′ ends of the murine adenosine deaminase gene. J. Biol. Chem. 265:1990;12513-12519.
84. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:1987;947-950.
85. Kozak M. The scanning model for translation: An update. J. Cell Biol. 108:1989;229-241.
86. Liu C. C., Simonsen C. C., Levinson A. D. Initiation of translation at internal AUG codons in mammalian cells. Nature. 309:1984;82-85.
87. Kozak M. Selection of initiation sites by eucaryotic ribosomes: Effect of inserting AUG triplets upstream from the coding sequence for preproinsulin. Nucleic Acids Res. 12:1984;3873-3893.
88. Grens A., Scheffler I. E. The 5′- and 3′-untranslated regions of ornithine decarboxylase mRNA affect the translational efficiency. J. Biol. Chem. 265:1990;11810-11816.
89. Pelletier J., Sonenberg N. The involvement of mRNA secondary structure in protein synthesis. Biochem. Cell Biol. 65:1987;576-581.
90. Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA. 83:1986;2850-2854.
91. Stein I., Itin A., Einat P., Skaliter R., Grossman Z., Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia. Mol. Cell. Biol. 18:1998;3112-3119.
92. Gueydan C., Droogmans L., Chalon P., Huez G., Caput D., Kruys V. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor α mRNA. J. Biol. Chem. 274:1999;2322-2326.
93. McCaughan K. K., Brown C. M., Dalphin M. E., Berry M. J., Tate W. P. Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc. Natl. Acad. Sci. USA. 92:1995;5431-5435.
94. Gutman G. A., Hatfield G. W. Nonrandom utilization of codon pairs in Escherichia coli. Proc. Natl. Acad. Sci. USA. 86:1989;3699-3703.
95. Sharp P. M., Cowe E., Higgins D. G., Shields D. C., Wolfe K. H., Wright F. Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and Homo sapiens: A review of the considerable within-species diversity. Nucleic Acids Res. 16:1988;8207-8211.
96. de Boer H. A., Kastelein R. A. Biased codon usage: An exploration of its role in optimization of translation. Reznikoff W., Gold L. Maximizing Gene Expression. 1986;225-285 Butterworths, Boston.
97. Kane J. F. Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. Curr. Opin. Biotechnol. 6:1995;494-500.
98. Zhang S., Zubay G., Goldman E. Low-usage codons in Escherichia coli, yeast, fruit fly and primates. Gene. 105:1991;61-72.
99. Wheeler V. C., Prodromou C., Pearl L. H., Williamson R., Coutelle C. Synthesis of a modified gene encoding human ornithine transcarbamylase for expression in mammalian mitochondrial and universal translation systems: A novel approach towards correction of a genetic defect. Gene. 169:1996;251-255.
100. Zolotukhin S., Potter M., Hauswirth W. W., Guy J., Muzyczka N. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:1996;4646-4654.
101. Yang T.-T., Cheng L., Kain S. R. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res. 24:1996;4592-4593.
102. Chiu W. L., Niwa Y., Zeng W., Hirano T., Kobayashi H., Sheen J. Engineered GFP as a vital reporter in plants. Curr. Biol. 6:1996;325-330.
103. Haas J., Park E.-C., Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6:1996;315-324.
104. André S., Seed B., Eberle J., Schraut W., Bultmann A., Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1998;1497-1503.
105. Uchijima M., Yoshida A., Nagata T., Koide Y. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J. Immunol. 161:1998;5594-5599.
106. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 59:1995;423-450.
107. Russell J. E., Morales J., Liebhaber S. A. The role of mRNA stability in the control of globin gene expression. Prog. Nucleic Acid Res. Mol. Biol. 57:1997;249-287.
108. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA. 83:1986;1670-1674.
109. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
110. Chen C. Y. A., Shyu A. B. AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:1995;465-470.
111. Zubiaga A. M., Belasco J. G., Greenberg M. E. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15:1995;2219-2230.
112. Lagnado C. A., Brown C. Y., Goodall G. J. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14:1994;7984-7995.
113. Carrier T. A., Keasling J. D. Library of synthetic 5′ secondary structures to manipulate mRNA stability in Escherichia coli. Biotechnol. Prog. 15:1999;58-64.
114. Hedley M. L., Strominger J. L., Urban R. G. Plasmid DNA encoding targeted naturally processed peptides generates protective cytotoxic T lymphocyte responses in immunized animals. Hum. Gene Ther. 9:1998;325-332.
115. Strong T. V., Hampton T. A., Louro I., Bilbao G., Conry R. M., Curiel D. T. Incorporation of β-globin untranslated regions into a Sindbis virus vector for augmentation of heterologous mRNA expression. Gene Ther. 4:1997;624-627.
116. Brawerman G. Belasco J. G., Brawerman G. Control of messenger RNA stability. 1993;149-159 Academic Press, San Diego.
117. Ross J. Control of messenger RNA stability in higher eukaryotes. Trends Genet. 12:1996;171-175.
118. Cañete-Soler R., Schwartz M. L., Hua Y., Schlaepfer W. W. Stability determinants are localized to the 3′-untranslated region and 3′-coding region of the neurofilament light subunit mRNA using a tetracycline-inducible promoter. J. Biol. Chem. 273:1998;12650-12654.
119. DeMaria C. T., Brewer G. AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271:1996;12179-12184.
120. Wilson G. M., Brewer G. The search for trans-acting factors controlling messenger RNA decay. Prog. Nucleic Acid Res. Mol. Biol. 62:1999;257-291.
121. Zaidi S. H. E., Malter J. S. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3′-untranslated region. J. Biol. Chem. 269:1994;24007-24013.
122. Holcik M., Liebhaber S. A. Four highly stable eukaryotic mRNAs assemble 3′ untranslated region RNA-protein complexes sharing cis and trans components. Proc. Natl. Acad. Sci. USA. 94:1997;2410-2414.
123. Paulding W. R., Czyzyk-Krzeska M. F. Regulation of tyrosine hydroxylase mRNA stability by protein-binding, pyrimidine-rich sequence in the 3′-untranslated region. J. Biol. Chem. 274:1999;2532-2538.
124. Murby M., Uhlén M., Ståhl S. Upstream strategies to minimize proteolytic degradation upon recombinant production in Escherichia coli. Protein Expression Purif. 7:1996;129-136.
125. Sharipo A., Imreh M., Leonchiks A., Imreh S., Masucci M. G. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: A new mechanism for selective inhibition of proteolysis. Nat. Med. 4:1998;939-944.
126. Leonchiks A., Liepinsh E., Barishev M., Sharipo A., Masucci M. G., Otting G. Random coil conformation of a Gly/Ala-rich insert in IκBα excludes structural stabilization as the mechanism for protection against proteasomal degradation. FEBS Lett. 440:1998;365-369.
127. Pelletier J., Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:1988;320-325.
128. Borman A. M., Le Mercier P., Girard M., Kean K. M. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 25:1997;925-932.
129. Yang Q., Sarnow P. Location of the internal ribosome entry site in the 5′ noncoding region of the immunoglobulin heavy-chain binding protein (BiP) mRNA: Evidence for specific RNA-protein interactions. Nucleic Acids Res. 25:1997;2800-2807.
130. Venkatesan A., Das S., Dasgupta A. Structure and function of a small RNA that selectively inhibits internal ribosome entry site-mediated translation. Nucleic Acids Res. 27:1999;562-572.
131. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene. 234:1999;187-208.
132. McCarthy J. E. G. Posttranscriptional control of gene expression in yeast. Microbiol. Mol. Biol. Rev. 62:1998;1492-1553.
133. Koo H.-M., Brown A. M. C., Kaufman R. J., Prorock C. M., Ron Y., Dougherty J. P. A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA. Virology. 186:1992;669-675.
134. Kaufman R. J. Strategies for obtaining high level expression in mammalian cells. Technique. 2:1990;221-236.
135. Davies M. V., Kaufman R. J. Internal translation initiation in the design of improved expression vectors. Curr. Opin. Biotechnol. 3:1992;512-517.
136. Mountford P. S., Smith A. G. Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet. 11:1995;179-184.
137. Gurtu V., Yan G., Zhang G. IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines. Biochem. Biophys. Res. Commun. 229:1996;295-298.
138. Rees S., Coote J., Stables J., Goodson S., Harris S., Lee M. G. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. BioTechniques. 20:1996;102-112.
139. Pu H., Cashion L. M., Kretschmer P. J., Liu Z. Rapid establishment of high-producing cell lines using dicistronic vectors with glutamine synthetase as the selection marker. Mol. Biotechnol. 10:1998;17-25.
140. Mosser D. D., Caron A. W., Bourget L., Jolicoeur P., Massie B. Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products. BioTechniques. 22:1997;150-161.
141. Clarke N. J., Hissey P., Buchan K., Harris S. pPV: A novel IRES-containing vector to facilitate plasmid immunization and antibody response characterization. Immunotechnol. 3:1997;145-153.
142. Sugimoto Y., Aksentijevich I., Gottesman M. M., Pastan I. Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site. Bio/Technology. 12:1994;694-698.
143. Wood C. R., Morris G. E., Alderman E. M., Fouser L., Kaufman R. J. An internal ribosome binding site can be used to select for homologous recombinants at an immunoglobulin heavy-chain locus. Proc. Natl. Acad. Sci. USA. 88:1991;8006-8010.
144. Fussenegger M., Bailey J. E., Hauser H., Mueller P. P. Genetic optimization of recombinant glycoprotein production by mammalian cells. Trends Biotechnol. 17:1999;35-42.
145. Lewis J. C., Feltus A., Ensor C. M., Ramanathan S., Daunert S. Applications of reporter genes. Anal. Chem. 70:1998;579A-585A.
146. Shetty R. S., Ramanathan S., Badr I. H., Wolford J. L., Daunert S. Green fluorescent protein in the design of a living biosensing system for L-arabinose. Anal. Chem. 71:1999;763-768.
147. Carter P. Site-specific proteolysis of fusion proteins. Ladisch M. R., Willson R. C., Painton C. C., Builder S. E. Protein Purification: From Molecular Mechanisms to Large-Scale Processes. 1990;181-193 Am. Chem. Soc. Washington.
148. Persic L., Righi M., Roberts A., Hoogenboom H. R., Cattaneo A., Bradbury A. Targeting vectors for intracellular immunisation. Gene. 187:1997;1-8.
149. Rondon I. J., Marasco W. A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51:1997;257-283.
150. Brightwell G., Poirier V., Cole E., Ivins S., Brown K. W. Serum-dependent and cell cycle-dependent expression from a cytomegalovirus-based mammalian expression vector. Gene. 194:1997;115-123.
151. Roizman B. The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors. Proc. Natl. Acad. Sci. USA. 93:1996;11307-11312.
152. Sclimenti C. R., Calos M. P. Epstein-barr virus vectors for gene expression and transfer. Curr. Opin. Biotechnol. 9:1998;476-479.
153. Chen Y.-T., Nelson W. J. Continuous production of soluble extracellular domain of a type-I transmembrane protein in mammalian cells using an Epstein-Barr virus Ori-P-based expression vector. Anal. Biochem. 242:1996;276-278.
154. Rabinowitz J. E., Samulski J. Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol. 9:1998;470-475.
155. Berkner K. L. Expression of heterologous sequences in adenoviral vectors. Curr. Top. Microbiol. Immunol. 158:1992;39-66.
156. Massie B., Dionne J., Lamarche N., Fleurent J., Langelier Y. Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Bio/Technology. 13:1995;602-608.
157. Carroll M. W., Moss B. Poxviruses as expression vectors. Curr. Opin. Biotechnol. 8:1997;573-577.
158. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA. 93:1996;11341-11348.
159. Condreay J. P., Witherspoon S. M., Clay W. C., Kost T. A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. USA. 96:1999;127-132.
160. Smerdou C., Liljeström P. Two-helper RNA system for production of recombinant Semliki Forest virus particles. J. Virol. 73:1999;1092-1098.
161. Garoff H., Li K.-J. Recent advances in gene expression using alphavirus vectors. Curr. Opin. Biotechnol. 9:1998;464-469.
162. Huang H. V. Sindbis virus vectors for expression in animal cells. Curr. Opin. Biotechnol. 7:1996;531-535.
163. Agapov E. V., Frolov I., Lindenbach B. D., Pragai B. M., Schlesinger S., Rice C. M. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc. Natl. Acad. Sci. USA. 95:1998;12989-12994.
164. Andino R., Silvera D., Suggett S. D., Achacoso P. L., Miller C. J., Baltimore D., Feinberg M. B. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science. 265:1994;1448-1451.
165. Basak S., McPherson S., Kang S., Collawn J. F., Morrow C. D. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2. J. Interferon Cytokine Res. 18:1998;305-313.
166. Mebatsion T., Schnell M. J., Cox J. H., Finke S., Conzelmann K. K. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl. Acad. Sci. USA. 93:1996;7310-7314.
167. García-Sastre A., Muster T., Barclay W. S., Percy N., Palese P. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J. Virol. 68:1994;6254-6261.
168. + responses in mice. Proc. Natl. Acad. Sci. USA. 95:1998;3954-3959.
169. He B., Paterson R. G., Ward C. D., Lamb R. A. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology. 237:1997;249-260.
170. Bukreyev A., Camargo E., Collins P. L. Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J. Virol. 70:1996;6634-6641.
171. Pushko P., Parker M., Ludwig G. V., Davis N. L., Johnston R. E., Smith J. F. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology. 239:1997;389-401.
172. Caley I. J., Betts M. R., Irlbeck D. M., Davis N. L., Swanstrom R., Frelinger J. A., Johnston R. E. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J. Virol. 71:1997;3031-3038.
173. Khromykh A. A., Westaway E. G. Subgenomic replicons of the flavivirus Kunjin: Construction and applications. J. Virol. 71:1997;1497-1505.
174. Hasan M. K., Kato A., Shioda T., Sakai Y., Yu D., Nagai Y. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J. Gen. Virol. 78:1997;2813-2820.
175. Roberts A., Kretzschmar E., Perkins A. S., Forman J., Price R., Buonocore L., Kawaoka Y., Rose J. K. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72:1998;4704-4711.
176. Naldini L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9:1998;457-463.
177. Miller A. D. Cell-surface receptors for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. USA. 93:1996;11407-11413.
178. Dubensky T. W. Jr., Driver D. A., Polo J. M., Belli B. A., Latham E. M., Ibanez C. E., Chada S., Brumm D., Banks T. A., Mento S. J., Jolly D. J., Chang S. M. Sindbis virus DNA-based expression vectors: Utility for in vitro and in vivo gene transfer. J. Virol. 70:1996;508-519.
179. Fisher K. J., Kelley W. M., Burda J. F., Wilson J. M. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum. Gene Ther. 7:1996;2079-2087.
180. DiCiommo D. P., Bremner R. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J. Biol. Chem. 273:1998;18060-18066.
181. Hannan G. N., Lehnert S. A., MacAvoy E. S., Jennings P. A., Molloy P. L. An engineered PGK promoter and lac operator-repressor system for the regulation of gene expression in mammalian cells. Gene. 130:1993;233-239.
182. Edamatsu H., Kaziro Y., Itoh H. Inducible high-level expression vector for mammalian cells, pEF-LAC carrying human elongation factor 1α promoter and lac operator. Gene. 187:1997;289-294.
183. Mizushima S., Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:1990;5322.
184. Friedman J. S., Cofer C. L., Anderson C. L., Kushner J. A., Gray P. P., Chapman G. E., Stuart M. C., Lazarus L., Shine J., Kushner P. J. High expression in mammalian cells without amplification. Bio/Technology. 7:1989;359-362.
185. Mori T., Yamamoto K., Ohta T., Sakamoto C., Sato M., Koide K., Murakami T., Fujii M., Fukuda S., Kurimoto M. A high-level and regulatable production system for recombinant glycoproteins using a human interferon-α promoter-based expression vector. Gene. 144:1994;289-293.
186. Mader S., White J. H. A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells. Proc. Natl. Acad. Sci. USA. 90:1993;5603-5607.
187. De Benedetti A., Rhoads R. E. A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells. Nucleic Acids Res. 19:1991;1925-1931.
188. Mäkelä T. P., Partanen J., Schwab M., Alitalo K. Plasmid pLTRpoly: A versatile high-efficiency mammalian expression vector. Gene. 118:1992;293-294.
189. Xu A., Kudo S., Fukuda M. A novel expression vector composed of a regulatory element of the human leukosialin-encoding gene in different types of mammalian cells. Gene. 160:1995;283-286.
190. Bartlett J. S., Sethna M., Ramamurthy L., Gowen S. A., Samulski R. J., Marzluff W. F. Efficient expression of protein coding genes from the murine U1 small nuclear RNA promoters. Proc. Natl. Acad. Sci. USA. 93:1996;8852-8857.
191. Takebe Y., Seiki M., Fujisawa J.-I., Hoy P., Yokota K., Arai K.-I., Yoshida M., Arai N. SRα promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:1988;466-472.
192. Chu T.-H. T., Martinez I., Olson P., Dornburg R. Highly efficient eukaryotic gene expression vectors for peptide secretion. BioTechniques. 18:1995;890-899.
193. Hendricks M. B., Banker M. J., McLaughlin M. A high-efficiency vector for expression of foreign genes in myeloma cells. Gene. 64:1988;43-51.
194. Furebring C., Ohlin M., Pettersson S., Borrebaeck C. A. K. Evaluation of novel control elements by construction of eukaryotic expression vectors. Gene. 188:1997;191-198.
195. Hippenmeyer P., Highkin M. High level, stable production of recombinant proteins in mammalian cell culture using the herpesvirus VP16 transactivator. Bio/Technology. 11:1993;1037-1041.
196. Alt F. W., Kellems R. E., Bertino J. R., Schimke R. T. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J. Biol. Chem. 253:1978;1357-1370.
197. Wigler M., Perucho M., Kurtz D., Dana S., Pellicer A., Axel R., Silverstein S. Transformation of mammalian cells with an amplifiable dominant-acting gene. Proc. Natl. Acad. Sci. USA. 77:1980;3567-3570.
198. Simonsen C. C., Levinson A. D. Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl. Acad. Sci. USA. 80:1983;2495-2499.
199. Mulligan R. C., Berg P. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA. 78:1981;2072-2076.
200. Colbere-Garapin F., Horodniceanu F., Kourilsky P., Garapin A. C. A new dominant hybrid selective marker for higher eukaryotic cells. J. Mol. Biol. 150:1981;1-14.
201. Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:1982;327-341.
202. Gritz L., Davies J. The sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene. 25:1983;179-188.
203. Bernard H. U., Krämmer G., Röwekamp W. G. Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp. Cell Res. 158:1985;237-243.
204. Vara J. A., Portela A., Ortin J., Jimenez A. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res. 14:1986;4617-4624.
205. de la Luna S., Ortin J. pac gene as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol. 216:1992;376-385.
206. Mulsant P., Gatignol A., Dalens M., Tiraby G. Phleomycin resistance as a dominant selectable marker in CHO cells. Somat. Cell Mol. Genet. 14:1988;243-252.
207. Sugiyama M., Thompson C. J., Kumagai T., Suzuki K., Deblaere R., Villarroel R., Davies J. Characterisation by molecular cloning of two genes from Streptomyces verticillus encoding resistance to bleomycin. Gene. 151:1994;11-16.
208. Hartman S. C., Mulligan R. C. Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. USA. 85:1988;8047-8051.
209. Pauw P. G., Johnson M. D., Moore P., Morgan M., Fineman R. M., Kalka T., Ash J. F. Stable gene amplification and overexpression of sodium- and potassium-activated ATPase in HeLa cells. Mol. Cell. Biol. 6:1986;1164-1171.
210. Emanuel J. R., Schulz J., Zhou X. M., Kent R. B., Housman D., Cantley L., Levenson R. Expression of an ouabain-resistant Na,K-ATPase in CV-1 cells after transfection with a cDNA encoding the rat Na,K-ATPase α1 subunit. J. Biol. Chem. 263:1988;7726-7733.
211. Yeung C. Y., Ingolia D. E., Bobonis C., Dunbar B. S., Riser M. E., Siciliano M. J., Kellems R. E. Selective overproduction of adenosine deaminase in cultured mouse cells. J. Biol. Chem. 258:1983;8338-8345.
212. Kaufman R. J., Murtha P., Ingolia D. E., Yeung C.-Y., Kellems R. E. Selection and amplification of heterologous genes encoding adenosine deaminase in mammalian cells. Proc. Natl. Acad. Sci. USA. 83:1986;3136-3140.
213. Wahl G. M., Padgett R. A., Stark G. R. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. J. Biol. Chem. 254:1979;8679-8689.
214. Wei K., Huber B. E. Cytosine deaminase gene as a positive selection marker. J. Biol. Chem. 271:1996;3812-3816.
215. Mullen C. A., Kilstrup M., Blaese R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. USA. 89:1992;33-37.
216. Cheng Y. C., Huang E. S., Lin J. C., Mar E. C., Pagano J. S., Dutschman G. E., Grill S. P. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA. 80:1983;2767-2770.
217. Lupton S. D., Brunton L. L., Kalberg V. A., Overell R. W. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11:1991;3374-3378.
218. Schwartz F., Maeda N., Smithies O., Hickey R., Edelmann W., Skoultchi A., Kucherlapati R. A dominant positive and negative selectable gene for use in mammalian cells. Proc. Natl. Acad. Sci. USA. 88:1991;10416-10420.
219. Karreman C. New positive/negative selectable markers for mammalian cells on the basis of Blasticidin deaminase-thymidine kinase fusions. Nucleic Acids Res. 26:1998;2508-2510.
220. Karreman C. A new set of positive/negative selectable markers for mammalian cells. Gene. 218:1998;57-61.
221. Knappik A., Plückthun A. An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. BioTechniques. 17:1994;754-761.
222. Chubet R. G., Brizzard B. L. Vectors for expression and secretion of FLAG epitope-tagged proteins in mammalian cells. BioTechniques. 20:1996;136-141.
223. Janknecht R., Nordheim A. Affinity purification of histidine-tagged proteins transiently produced in HeLa cells. Gene. 121:1992;321-324.
224. Witzgall R., O'Leary E., Bonventre J. V. A mammalian expression vector for the expression of GAL4 fusion proteins with an epitope tag and histidine tail. Anal. Biochem. 223:1994;291-298.
225. Chatton B., Bahr A., Acker J., Kedinger C. Eukaryotic GST fusion vector for the study of protein-protein associations in vivo: Application to interaction of ATFa with Jun and Fos. BioTechniques. 18:1995;142-145.
226. Rudert F., Visser E., Gradl G., Grandison P., Shemshedini L., Wang Y., Grierson A., Watson J. pLEF, a novel vector for expression of glutathione S-transferase fusion proteins in mammalian cells. Gene. 169:1996;281-282.
227. Manoharan H. T., Gallo J., Gulick A. M., Fahl W. E. High-level production and purification of biologically active proteins from bacterial and mammalian cells using the tandem pGFLEX expression system. Gene. 193:1997;229-237.
228. Capon D. J., Chamow S. M., Mordenti J., Marsters S. A., Gregory T., Mitsuya H., Byrn R. A., Lucas C., Wurm F. M., Groopman J. E., Broder S., Smith D. H. Designing CD4 immunoadhesins for AIDS therapy. Nature. 337:1989;525-531.
229. Lo K.-M., Sudo Y., Chen J., Li Y., Lan Y., Kong S.-M., Chen L. L., An Q., Gillies S. D. High level expression and secretion of Fc-X fusion proteins in mammalian cells. Protein Eng. 11:1998;495-500.
230. Zettlmeissl G., Gregersen J.-P., Duport J. M., Mehdi S., Reiner G., Seed B. Expression and characterization of human CD4:immunoglobulin fusion proteins. DNA Cell Biol. 9:1990;347-353.
231. Makrides S. C., Nygren P.-Å., Andrews B., Ford P. J., Evans K. S., Hayman E. G., Adari H., Uhlén M., Toth C. A. Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor. J. Pharmacol. Exp. Ther. 277:1996;534-542.
232. Yeh P., Landais D., Lemaitre M., Maury I., Crenne J.-Y., Becquart J., Murry-Brelier A., Boucher F., Montay G., Fleer R., Hirel P.-H., Mayaux J.-F., Klatzmann D. Design of yeast-secreted albumin derivatives for human therapy: Biological and antiviral properties of a serum albumin-CD4 genetic conjugate. Proc. Natl. Acad. Sci. USA. 89:1992;1904-1908.
233. Gupta A., Chandrasekhar S., Pal R., Talwar G. P., Singh O. M. Identification of novel transmembrane gene sequence and its use for cell-surface targeting of beta subunit of human chorionic gonadotropin. DNA Cell Biol. 17:1998;573-581.
234. Paborsky L. R., Fendly B. M., Fisher K. L., Lawn R. M., Marks B. J., McCray G., Tate K. M., Vehar G. A., Gorman C. M. Mammalian cell transient expression of tissue factor for the production of antigen. Protein Eng. 3:1990;547-553.
235. Selden R. F., Howie K. B., Rowe M. E., Goodman H. M., Moore D. D. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6:1986;3173-3179.
236. Alam J., Cook J. L. Reporter genes: Application to the study of mammalian gene transcription. Anal. Biochem. 188:1990;245-254.
237. Henthorn P., Zervos P., Raducha M., Harris H., Kadesch T. Expression of a human placental alkaline phosphatase gene in transfected cells: Use as a reporter for studies of gene expression. Proc. Natl. Acad. Sci. USA. 85:1988;6342-6346.
238. Berger J., Hauber J., Hauber R., Geiger R., Cullen B. R. Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 66:1988;1-10.
239. Kaestner K. H., Montoliu L., Kern H., Thulke M., Schütz G. Universal β-galactosidase cloning vectors for promoter analysis and gene targeting. Gene. 148:1994;67-70.
240. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
241. Luckow B., Schutz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:1987;5490.
242. Pazzagli M., Devine J. H., Peterson D. O., Baldwin T. O. Use of bacterial and firefly luciferases as reporter genes in DEAE-dextran-mediated transfection of mammalian cells. Anal. Biochem. 204:1992;315-323.
243. Stratowa C., Himmler A., Czernilofsky A. P. Use of a luciferase reporter system for characterizing G-protein-linked receptors. Curr. Opin. Biotechnol. 6:1995;574-581.
244. Beckers T., Reiländer H., Hilgard P. Characterization of gonadotropin-releasing hormone analogs based on a sensitive cellular luciferase reporter gene assay. Anal. Biochem. 251:1997;17-23.
245. Liu J., O'Kane D. J., Escher A. Secretion of functional Renilla reniformis luciferase by mammalian cells. Gene. 203:1997;141-148.
246. Stauber R. H., Horie K., Carney P., Hudson E. A., Tarasova N. I., Gaitanaris G. A., Pavlakis G. N. Development and applications of enhanced green fluorescent protein mutants. BioTechniques. 24:1998.
247. Cheng L. Z., Fu J., Tsukamoto A., Hawley R. G. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat. Biotechnol. 14:1996;606-609.
248. Mo Y.-Y., Ameiss K. A., Beck W. T. Overexpression of human DNA topoisomerase IIα by fusion to enhanced green fluorescent protein. BioTechniques. 25:1998;1052-1057.